Related Experiment Video
Updated: Aug 7, 2026
07:56
Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
Published on: November 11, 2020
Litigating the hype: the Lung Health Institute class action and its implications
Mark Alonzo1, Bambi J Grilley2, Daniel J Weiss3
1Vinson Law, P.A., Tampa, Florida, USA.
Cytotherapy
|August 5, 2026
Summary
Patient lawsuits highlight regulatory gaps in unproven stem cell therapies. Lessons learned from the Lung Institute case inform strategies against deceptive stem cell interventions globally.
Area of Science:
- Biomedical Law
- Regulatory Science
- Cell Therapy
Background:
- Patient lawsuits, such as the Lung Institute case, underscore issues with unproven "stem cell" interventions.
- Existing regulations for cell therapies contrast with practical enforcement challenges observed in such cases.
Purpose of the Study:
- To analyze regulatory and litigation strategies concerning unproven stem cell therapies.
- To identify lessons for coordinated enforcement and the role of scientific experts in addressing deceptive claims.
Main Methods:
- Case study analysis of the Lung Institute class action lawsuit.
- Comparative review of US laws and regulations governing cell therapies.
- Discussion of enforcement and litigation strategies.
Main Results:
- The Lung Institute case revealed significant gaps between current regulations and the reality of unproven stem cell interventions.
- Coordinated, multipronged strategies are needed for effective enforcement and litigation.
- Scientists play a crucial role as expert witnesses in cases involving fraudulent stem cell claims.
Conclusions:
- Lessons from US regulations and litigation regarding unproven stem cell therapies offer global applicability.
- Addressing the proliferation of unproven stem cell interventions requires robust, internationally coordinated oversight.
- Proactive strategies are essential to protect patients from deceptive and harmful stem cell treatments, even in highly regulated environments.
Related Concept Videos
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:19Respiratory Assessment: Purpose and Indications
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...